MEDICATION ADHERENCE AND PERSISTANCE IN TYPE 2 DIABETES MELLITUS (T2DM)- PATIENTS PERSPECTIVE IN THE SPANISH HEALTH CARE SYSTEM
Author(s)
Labrador Barba E1, Hernandez Mijares A2, Alonso Moreno FJ3, Rodriguez de Miguel M1, Orera Peña ML1, Aceituno Mata S4, Perez L4, Faus Dader MJ5
1Mylan, Barcelona, Spain, 2Dr. Peset Hospital, Valencia, Spain, 3Sillería Health Center, Toledo, Spain, 4Outcomes’10, Castellon, Spain, 5Faculty of Pharmacy, Granada, Spain
OBJECTIVES: To elicit type 2 diabetes mellitus (T2DM) patients’ perception regarding the factors influencing medication adherence together with the strategies aimed to improve it. METHODS: An observational, cross-sectional study was conducted. An electronic self-administered questionnaire containing 11 questions (5-likert scale) was designed in order to address the importance given by patients to different factors and strategies associated with medication adherence. In addition, patient’s adherence (Morisky-green) along with sociodemographic and clinical variables were collected. A multiple multinomial logistic regression was performed to assess explanatory variables. RESULTS: A total of 963 T2DM patients participated in the study (49.9% female; mean age 60.4 years). To achieve good medication adherence, the majority of patients considered “important” or “very important” their knowledge about disease (92.2%) and treatment (91.4%) and the treatment information provided by doctor (94%). Moreover, most subjects placed a great importance to disease features such as the chronicity (86.8%), presence of comorbidities (82.4%) or complications (80.5%). A lesser percentage of patients (55.4%), perceived that environmental characteristics such as “family member or friend having the condition” or medication features like “complexity of medication container” (57.2%) were relevant to adherence. Related to the strategies aimed to improve adherence, nearly half of participants (43%) agreed that to adjust treatment regimen to activities of daily living was the best strategy to reduce therapeutic complexity, while the use of weekly and daily pill dispensers were considered the most effective technique to improve their adherence (71.3 and 71.2%, respectively). Compared to non-adherent (p<0,005), adherent patient considered more important their treatment confidence and knowledge about disease (p=0,003), treatment (p=0,002) and adherence consequences as factors that determine their adherence. CONCLUSIONS: This information may help to incorporate a greater patient centeredness and guide medical decision-making in order to improve T2DM patient’s adherence and clinical outcomes.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
AD3
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Diabetes/Endocrine/Metabolic Disorders